🇺🇸 Relmacabtagene Autoleucel Injection in United States

Relmacabtagene Autoleucel Injection (Relmacabtagene Autoleucel Injection) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Relmacabtagene Autoleucel Injection in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Relmacabtagene Autoleucel Injection approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Relmacabtagene Autoleucel Injection in United States?

Changhai Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.